From: A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation
Absorption
Dead cells, %
CI
Tumor cells (targets)
1.363
Leucocytes (effectors)
0.34
Untreated mouse
1.42
20.9
Control (tumor only)
1.706
-0.2
-21.1
Dox+CP
1.424
20.5
-0.4
DNA
0.815
65.1
44.2
Dox+CP+DNA
0.239
107.4
86.5